IVISense™ Edema (Superhance™ 680) fluorescent probe is a blood pooling imaging agent for imaging circulation, blood vessels, vasculature, vascular leak, including that associated with early oncologic and ophthalmologic lesions. This agent has a short pharmacokinetic profile with bladder clearance, and binds to albumin in blood for a modestly extended (30m-1h) circulation half-life.
For research use only. Not for use in diagnostic procedures.
false false
IVISense Edema fluorescent probe is a small molecule near infrared fluorescent probe designed for in vivo preclinical intravenous administration. This probe, being of low molecular weight, will leak and pool in regions of acute edema or vascular leak associated with oncology or other diseases. It is ideal for imaging vascularity, perfusion, and vascular permeability.
Benefits of IVISense Edema 680 fluorescent probe:
| 熒光劑類型 | Vascular |
|---|---|
| 光學成像分類 | Fluorescence Imaging |
| 產品品牌名稱 | IVISense |
| 包裝量 | 1.0 Units |
| 運輸條件 | 環境 |
| 治療領域 | Vascular disease, Angiogenesis, Inflammation, Oncology/Cancer |
| 產品尺寸 | 1 Vial (10 doses) |
| 波長 | 680 nm |
Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And ...
Our comprehensive range of bioluminescent and fluorescent imaging reagents provide researchers with the necessary tools to better understand early disease-related biological changes, track disease progression, help guide the drug discovery process, and evaluate efficacy and safety of drug candida ...
Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into disease processes and treatment effects. Designing an effective study from the beginning can help save time and resources.
Learn about several important best p ...
Optical-based in vivo imaging of vascular changes and vascular leak is an emerging modality for studying altered physiology in a variety of different cancers and inflammatory states. A number of fluorescent imaging probes that circulate with the blood, but have no target selectivity, have been used ...
The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and biological functioning to better understand and characterize disease processes and treatment effects earlier within the context of a biological system.
This s ...
The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick ...
